Page 8 - Intramural Research Program News Today

In a study that followed more than 2,000 community-dwelling older adults over eight years, researchers at Johns Hopkins Medicine say they have significant new evidence of a link between decreased sense of smell and risk of developing late-life depression.

Researchers identified a correlation between loss of smell and an increased risk of developing late-life depression.

"Smell is an important way to engage with the world around us, and this study shows it may be a warning sign for late-life depression."

In an analysis of the Look AHEAD study, researchers from the Brigham and Joslin Diabetes Center found that participants who were physically active in the afternoon had greater reductions in blood sugar than those who were most active at other times of day. Over 37 million Americans have diabetes,

A new study in rats suggests that xylazine, the active ingredient in a non-opioid veterinary tranquilizer not approved for human use, can worsen the life-threatening effects of opioids.

MIAMI BEACH, Fla. — Treatment with ketamine may be an effective augmenter of risk mitigation for suicidality and effective modulator for suicide-related cognitive processing in adults, according to data presented here. “Since 1999, the trajectory (of suicide) has been on the rise,” Steven J. Lamontagne, PhD, postdoctoral fellow in the Division of Intramural Research Program at

Researchers have partnered to create a first-of-its-kind open-source, reproducible analysis platform for pediatric brain tumors. With the help of thousands of genomically sequenced samples, researchers have used this platform to identify initial findings about genetic variants associated with poorer outcomes that could help guide future diagnostic and therapeutic advances.

Researchers have partnered to create a first-of-its-kind open-source, reproducible analysis platform for pediatric brain tumors. With the help of thousands of genomically sequenced samples, researchers have used this platform to identify initial findings about genetic variants associated with poorer outcomes that could help guide future diagnostic and therapeutic advances.

"The death rate among youth aged 10 to 24 years increased 52.2% from 6.9 per 100,000 in 2001 to 10.5 per 100,000 in 2020."

A new study uses data from the Look AHEAD (Action for Health in Diabetes) study, a randomized controlled trial that compared an intensive lifestyle intervention with diabetes support and education in patients diagnosed with type 2 diabetes and overweight or obesity to track the development of cardiovascular disease over time.